Inventor · disambiguated record
Herve Watier
Also filed as: WATIER HERVE
1 granted patent·9 pending applications·3 citations·filing 2002–2016
25Inventor score
Files withWATIER HERVE4CHRU TOURS1COLOMBEL JEAN-FREDERIC1CT HOSPITALIER REGIONAL ET UNIVERSITAIRE DE TOURS1GLYCODE1
Top patents by PatentIndex Score
10 records- 0161US7858300B2Methods and compositions to evaluate antibody treatment responseCT HOSPITALIER REGIONAL ET UNIVERSITAIRE DE TOURS·Filed 2002·Granted Dec 28, 2010·3 cites·24 claims
- 0253US2015017633A1Methods and compositions to evaluate antibody treatment responseWATIER HERVE·Filed 2013·Application pending·0 cites
- 0350US2012027750A1Method and compositions for cancer prognosisWATIER HERVE·Filed 2009·Application pending·0 cites
- 0444US2011123996A1Methods and compositions to evaluate antibody treatment responseWATIER HERVE·Filed 2010·Application pending·0 cites
- 0542US2015065455A1Methods of assessing susceptibility to drug-induced thrombocytopeniaWATIER HERVE·Filed 2014·Application pending·0 cites
- 0640US2007190657A1Methods of assessing susceptibility to drug-induced thrombocytopeniaUNIV RABELAIS FRANCOIS·Filed 2005·Application pending·0 cites
- 0735US2006051353A1Methods and compositions to evaluate antibody treatment responseCOLOMBEL JEAN-FREDERIC·Filed 2005·Application pending·0 cites
- 0835US2007231813A1Fcgr3a Gebotype and Methods for Evaluating Treatment Response to Non-Depleting AntibodiesCHRU TOURS·Filed 2005·Application pending·0 cites
- 0927US2010167315A1Method for investigating the response to a treatment with a monoclonal antibodyGLYCODE·Filed 2007·Application pending·0 cites
- 1017US2018362624A1Ig1 and the therapeutic use thereofUNIV FRANCOIS RABELAIS DE TOURS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Herve Watier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →